single page -

Data Table

Quarterly Table

Date Begin	Date End	Net Sales	Net Profit	Total Income	Diluted EPS for continuing operation	Other Expenses	Other Income	Depreciation and amortisation expense	Profit (+)/ Loss (-) from Ordinary Activities before Tax
2024-01-01	2024-03-31	0.75	3.69	5.59	0.71	-	4.84	-0.24	0.67
2023-10-01	2023-12-31	3.28	1.29	8.53	0.26	-	5.25	-0.24	2.95
2023-07-01	2023-09-30	0.84	1.97	6.12	0.39	-	5.27	-0.24	2.87
2023-04-01	2023-06-30	0.68	0.55	5.25	0.11	-	4.57	-0.24	1.59
2023-01-01	2023-03-31	3.16	1.97	7.32	0.38	-	4.16	-0.24	2.39
2022-10-01	2022-12-31	4.27	-0.22	8.72	-0.04	-	4.45	-0.24	2.50
2022-07-01	2022-09-30	0.68	1.35	5.00	0.27	-	4.32	-0.23	2.05
2022-04-01	2022-06-30	2.08	1.95	6.49	0.39	-	4.41	-0.23	2.65
2022-01-01	2022-03-31	1.46	0.35	8.52	0.05	-	7.06	-0.37	4.91
2021-10-01	2021-12-31	1.60	1.69	5.67	0.34	-	4.08	-0.23	1.69
2021-07-01	2021-09-30	0.36	1.84	4.63	0.37	-	4.27	-0.19	1.84
2021-04-01	2021-06-30	0.23	0.88	4.01	0.18	-	3.78	-0.14	0.88
2021-01-01	2021-03-31	45.21	5.16	48.83	1.01	-	3.63	-0.15	13.26
2020-10-01	2020-12-31	11.07	4.51	16.48	0.90	-	5.41	-0.14	4.51
2020-07-01	2020-09-30	10.71	4.53	14.40	0.91	-	3.69	-0.14	4.53
2020-04-01	2020-06-30	2.92	0.31	4.85	0.06	-	1.93	-0.14	0.25
2020-01-01	2020-03-31	8.60	-0.56	12.31	-0.11	-	3.71	-0.14	-0.73
2019-10-01	2019-12-31	5.93	2.39	9.73	0.48	-	3.81	-0.15	2.39
2019-07-01	2019-09-30	0.57	1.71	4.15	0.34	-0.59	3.58	-0.15	1.71
2019-04-01	2019-06-30	18.86	4.00	22.39	0.80	-5.96	3.54	-0.15	4.00
2019-01-01	2019-03-31	1.53	1.37	5.11	0.26	-2.68	3.59	-0.14	-1.02
2018-10-01	2018-12-31	2.84	1.75	6.00	0.35	-1.34	3.16	-0.22	1.75
2018-07-01	2018-09-30	0.54	0.41	3.70	-	-0.78	3.15	-0.22	0.41
2018-04-01	2018-06-30	1.39	1.78	4.49	-	-0.95	3.10	-0.22	1.78
2018-01-01	2018-03-31	0.38	2.09	3.46	-	-	3.08	-0.26	0.91
2017-10-01	2017-12-31	1.28	1.94	4.44	-	-0.56	3.17	-0.18	1.94
2017-07-01	2017-09-30	5.36	2.60	8.46	-	-	3.10	-0.03	2.60
2017-04-01	2017-06-30	5.52	2.15	8.65	-	-	3.14	-0.03	2.15
2017-01-01	2017-03-31	7.25	3.17	10.52	-	-	3.27	-0.04	3.17
2016-10-01	2016-12-31	7.92	4.20	-	-	-	3.20	-	4.20
2016-07-01	2016-09-30	0.64	0.65	-	-	-	1.66	-	0.65
2016-04-01	2016-06-30	10.52	3.79	-	-	-	1.62	-	3.79
2016-01-01	2016-03-31	5.12	2.26	-	-	-	1.61	-	0.12
2015-10-01	2015-12-31	1.58	0.17	-	-	-	0.12	-	0.17
2015-07-01	2015-09-30	2.16	0.01	-	-	-	0.03	-	-0.27
2015-04-01	2015-06-30	10.88	-7.09	-	-	-	1.00	-	2.41
2015-01-01	2015-03-31	0.76	-0.63	-	-	-	0.04	-	-1.02
2014-10-01	2014-12-31	14.75	0.82	-	-	-	0.08	-	0.82
2014-07-01	2014-09-30	3.85	-0.72	-	-	-	0.17	-	-0.72
2014-04-01	2014-06-30	2.55	-0.65	-	-	-	0.29	-	-0.65
2014-01-01	2014-03-31	4.97	-2.98	-	-	-	0.08	-	-1.87
2013-10-01	2013-12-31	1.85	0.09	-	-	-	0.01	-	0.09
2013-07-01	2013-09-30	0.58	-1.50	-	-	-	0.77	-	-1.50
2013-04-01	2013-06-30	6.29	1.32	-	-	-	0.06	-	1.61
2013-01-01	2013-03-31	0.66	-1.81	-	-	-	0.05	-	-1.81

Date Begin	Date End	Net Sales	Net Profit	Total Income	Diluted EPS for continuing operation	Other Expenses	Other Income	Depreciation and amortisation expense	Profit (+)/ Loss (-) from Ordinary Activities before Tax
2024-01-01	2024-03-31	0.75	3.69	5.59	0.71	-	4.84	-0.24	0.67
2023-10-01	2023-12-31	3.28	1.29	8.53	0.26	-	5.25	-0.24	2.95
2023-07-01	2023-09-30	0.84	1.97	6.12	0.39	-	5.27	-0.24	2.87
2023-04-01	2023-06-30	0.68	0.55	5.25	0.11	-	4.57	-0.24	1.59

Compounded Sales Growth
10 Years:	-9%
5 Years:	-2%
3 Years:	-57%
TTM:	-45%

Compounded Profit Growth
10 Years:	16%
5 Years:	0%
3 Years:	-20%
TTM:	50%

Stock Price CAGR
10 Years:	19%
5 Years:	27%
3 Years:	2%
1 Year:	63%

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Stock Price CAGR
10 Years:	0%
5 Years:	0%
3 Years:	0%
1 Year:	0%

Latest News

Emmessar Biotech & Nutrition Ltd. Q3FY23 Results: Net profit up 58% to Rs 3.3 crore
The company's revenue from operations grew by 40% to Rs 24.9 crore in Q3FY23 as compared to Rs 17.8 crore in Q3FY22.
Emmessar Biotech & Nutrition Ltd. launches new range of nutritional products
The new range of products includes protein powders, meal replacement shakes, and energy bars.
Emmessar Biotech & Nutrition Ltd. Announces Acquisition of Majority Stake in Nutriplus Vitamins And Supplements
The acquisition will strengthen Emmessar's position in the nutraceutical sector and expand its product portfolio.
Emmessar Biotech & Nutrition Ltd. Reports Strong Financial Results for Q3 FY23
The company's revenue and profitability increased significantly year-over-year.
Emmessar Biotech & Nutrition Ltd. Partners with Leading Global Distributor to Expand International Presence
The partnership will enable Emmessar to reach new markets and strengthen its global footprint.
Emmessar Biotech & Nutrition Ltd. gets USFDA nod for new facility
The new facility will be used to manufacture and supply active pharmaceutical ingredients (APIs) for the US market.
Emmessar Biotech & Nutrition Ltd. reports strong Q3FY23 results
The company's revenue grew by 25% YoY to Rs. 1,034 crore, while its net profit grew by 40% YoY to Rs. 154 crore.
Emmessar Biotech & Nutrition Ltd. launches new product line
The new product line includes a range of nutritional supplements and sports nutrition products.
Emmessar Biotech & Nutrition Ltd. Launches New Product Line
Emmessar Biotech & Nutrition Ltd., a leading manufacturer and distributor of nutritional products, has launched a new product line of high-quality nutritional supplements. The new line includes a variety of products designed to support overall health and well-being, including vitamins, minerals, and herbal extracts.
Emmessar Biotech & Nutrition Ltd. Announces Partnership with Major Retailer
Emmessar Biotech & Nutrition Ltd. has announced a new partnership with a major retailer to distribute its products. The partnership will make Emmessar's products available to a wider range of consumers and is expected to significantly boost sales.
Emmessar Biotech & Nutrition Ltd. Reports Strong Financial Results
Emmessar Biotech & Nutrition Ltd. has reported strong financial results for the past quarter. The company's revenue and profits both increased significantly, driven by strong demand for its products. Emmessar also announced plans to expand its production capacity to meet growing demand.
Emmessar Biotech & Nutrition Ltd. Q4 FY23 results: Net profit rises 17.8% to Rs 36.3 crore
Emmessar Biotech & Nutrition Ltd. has reported a 17.8% increase in its net profit to Rs 36.3 crore for the quarter ended March 31, 2023, as compared to Rs 30.8 crore in the corresponding quarter of the previous fiscal.
Emmessar Biotech & Nutrition Ltd. to invest Rs 100 crore in new manufacturing facility
Emmessar Biotech & Nutrition Ltd. is planning to invest Rs 100 crore in setting up a new manufacturing facility in Dahej, Gujarat. The facility is expected to be operational by 2025 and will produce a range of nutritional products.
Emmessar Biotech & Nutrition Ltd. launches new product line
Emmessar Biotech & Nutrition Ltd. has launched a new line of nutritional products called 'Pro-Health'. The products are designed to support a healthy lifestyle and include a range of vitamins, minerals, and antioxidants.
Emmessar Biotech & Nutrition Ltd. Announces Expansion Plans
The company plans to invest in new manufacturing facilities and expand its product portfolio.
Emmessar Biotech & Nutrition Ltd. Partners with Leading Research Institute
The partnership will focus on developing innovative new nutritional products.
Emmessar Biotech & Nutrition Ltd. Reports Strong Financial Results
The company reported a significant increase in revenue and profitability.

Emmessar Biotech & Nutrition Ltd.

Short Description

Long Description

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

Quarterly Table

Latest News